Gossamer Threads Inc.: Health

Home: Health: LINKS_PAGE

Links:

Global Intraocular Lens Market to Witness Significant Revenue Growth Through 2020 - Cataract is the clouding of the eye lens. Cataract is the leading cause of blindness worldwide. Intraocular lens is a synthetic artificial lens placed to replace natural lens. Intraocular lenses are used for the surgical treatment of cataract. According to the World Health Organization (WHO), in 2010, approximately 20 million cataract surgeries were performed and are expected to reach approximately 32 million by 2020. Several types of intraocular lenses implants are available to improve vision. Monofocal intraocular lenses are best choice for limited budget. Whereas, premium intraocular lenses are specifically designed to reduce patients need for glasses. Tronic intraocular lenses, multifocal intraocular lenses and accommodating intraocular lenses are some of the premium intraocular lenses. North America dominates the global market for intraocular lens due to large number of aging population and availability of reimbursements. Asia is expected to show high growth rates in the next five years in the global intraocular lens market. China and India are expected to be the fastest growing intraocular lens markets in Asia-Pacific region. Some of the key driving forces for intraocular lens market in emerging countries are large pool of patients and rising government funding. Request For Report Sample@https://www.persistencemarketresearch.com/samples/3290 In recent times there is increased use of intraocular lens due to increasing prevalence of cataract in aging population. Rise in adoption of premium intraocular lens such as accommodating intraocular lens and multifocal intraocular lens and increasing government initiatives are some of the key factors driving the growth for global intraocular lens market. In addition, increasing healthcare awareness is also fuelling the growth of global intraocular lens market. However, high cost related with surgical procedure and post-operative complications such as refractive errors are some of the major factors restraining the growth for global intraocular lens market. Request For Report Table of Content (TOC): https://www.persistencemarketresearch.com/toc/3290 Availability of advance technologies such as micro-incision cataract surgery and femtosecond lasers would develop opportunities for global intraocular lens market. The trend for global intraocular lens market is multi-distance vision capabilities. Some of the major companies operating in the global intraocular lens market are Alcon, Inc., Abbott Medical Optics, Inc., Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Rayner Intraocular Lenses Limited, Eyekon Medical, Lenstec, HumanOptics AG, STAAR Surgical Company and Hoya Corporation. (Added: Mon Mar 18 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

Global Surgical Apparel Market to Witness Heightened Growth During the Period 2020 - Infection diseases mainly acquired in healthcare facility is one of the major cause deaths in the U.S. Surgical apparel is used to provide optimal level of protection by reducing the transfer of bacteria from the skin to the surgical staff. Surgical apparel is also known as surgical clothing. Some of the surgical appeals are surgical gloves, face masks, head wear, scrub suits, chemotherapy gowns, foot wear, drapes and surgical gowns. Surgical apparel is essential as there are always microorganisms on the skin even after conducting sterilization procedure and strict hygiene. Surgical apparels protect bacteria from entering the surgical wound. Surgical apparels also protect healthcare staff from bodily fluids, blood, saline, urine and other chemicals during surgical procedure. The U.S. dominates the North American market for surgical apparel due to large number of aging population and chronic diseases. The North American surgical apparel market is segmented on the basis of type of surgical apparel such as surgical gloves, surgical drapes, surgical gowns and surgical masks. Request For Report Sample@ https://www.persistencemarketresearch.com/samples/3288 In recent times there is increased use of surgical apparel due to increasing prevalence of infections and chronic diseases. Rise in aging population, increasing healthcare coverage resulting in increase in surgical procedures and increasing stringent regulations for patient and staff safety are some of the key factors driving the growth for the North American surgical apparel market. In addition, increasing incidence of hospital acquired infection is also fuelling the growth of the North American surgical apparel market. However, price fluctuation of raw material and strict regulatory requirements are some of the major factors restraining the growth for the North American surgical apparel market. Request For Report Table of Content (TOC): https://www.persistencemarketresearch.com/toc/3288 Emergence of biofunctional textile, non-conventional types of gloves and advanced composite technology would develop opportunity for the North American surgical apparel market. However, maintain a balance between quality and cost would pose a challenge for the North American surgical apparel market. The trend for the North American surgical apparel market is introduction of new products, such as MicroCool gowns, in the North American surgical apparel market. Some of the major companies operating in the North American surgical apparel market are Cardinal Health, Inc., DuPont Medical Fabrics, Kimberly-Clark Health Care and Medline Industries. (Added: Mon Mar 18 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

Global MicroRNA Tools and Services Market to Witness Rapid Development During the Period 2020 - Molecular diagnostics is a vast field that comprises of techniques and methods to analyze biomarkers in genetic code. It helps in encoding genomes and proteomes that are required for studying and detecting the disease, and thus help in deciding the best therapy for an individual. MicroRNA tools and services market is experiencing a significant growth due to increased R&D and rising government initiatives in this field. MicroRNA tools market is further segmented into quantitative real-time polymerase chain reaction (qRT-PCR), microarrays, and functional tools. Of which, qRT-PCR segments remains the largest and the fastest growing segment. MicroRNA services market is further segmented into phenotypic analysis and expression profiling and analysis. Request For Report Sample@ https://www.persistencemarketresearch.com/samples/3276 North America dominates the global microRNA tools and services market due to increased government initiatives and broad technical applications of microRNA tools and services in the region. Europe, followed by Asia, is expected to experience high growth rate in the next few years in global microRNA tools and services market. China and India are expected to be the fastest growing microRNA tools and services market in Asian region. This is due to increased investments from foreign companies in these countries. Some of the key driving forces for microRNA tools and services market in emerging countries are increasing R&D investment, improved healthcare facilities and rising government funding. Various factors such as growing awareness about microRNA technology, increasing government initiatives and accuracy of the results obtained have been driving the microRNA tools and services market. In addition, increased funding from various government and non-government organizations and increased availability of this technology has been driving the microRNA tools and services market. However, high cost involved and lack of experienced professionals has been restraining the growth of microRNA tools and services market. Request For Report Table of Content (TOC): https://www.persistencemarketresearch.com/toc/3276 Increased R&D and innovation of some new technology with better efficiency is expected to offer good opportunity for microRNA tools and services market. In addition, emerging markets hold a great potential for growth microRNA tools and services market. Some of the latest trends that have been observed in microRNA tools and services market are companies involved in partnerships and collaboration for R&D of novel products. Some of the major companies dealing in microRNA tools and services market include Qiagen, Life Technologies, Exiqon, GeneCopoeia, Inc and Mirus Bio. Some other companies dealing in microRNA tools and services market include Biomatik, Asurgen, Inc and Cell Biolabs Inc. (Added: Mon Mar 18 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

Brian Tuttle: Total HIPAA Compliance - Double Tree by Hilton Hotel, Rosemount, Chicago, IL- March 15th 2019- Brian Tuttle is a remarkable presenter and Keynote Speaker at Compliance Key. He is a Certified Professional in Health IT (CPHIT), Certified HIPAA Professional (CHP), Certified HIPAA Administrator (CHA), Certified Business Resilience Auditor (CBRA), Certified Information Systems Security Professional (CISSP) with over 18 years' experience in Health IT and Compliance Consulting and he is well versed with immense knowledge of HIPPA. HIPAA law regulates the use and disclosure of an individual’s health information in any format, also known as Protected Health Information (PHI). Performed by CPA firm SSAE 16 Professionals, LLP, the evaluation of compliance was designed to measure the strict controls Melissa has put into place to keep customer information private and secure Brian is well known and highly regarded in medical circles throughout the United States for his quality work and down home southern charm Mr Tuttle holds a Master's Degree in Health Sciences from Georgia State University and works nationally out of Kennesaw, GA. His expertise on services include: • HIPAA Security/Privacy auditing • Comprehensive NIST based risk assessments with mitigation • HIPAA awareness training and certification • Custom written policies and procedures • Public speaking • Specialized HIPAA Training • Subject matter writing • HIPAA consulting and certification for proprietary software companies • Business continuity (Disaster Recovery) planning and consulting With vast experience in health IT systems (i.e. practice management, EHR systems, imaging, transcription, medical messaging, etc.) as well as over 18 years’ experience in standard Health IT with multiple certifications and hands-on knowledge, Brian serves as compliance consultant and has conducted onsite and remote risk assessments for over 1000 medical practices, hospitals, health departments, insurance plans, and business associates throughout the United States. Outline Synopsis This seminar will be drawing attention how practice/business managers or compliance officers need to get their HIPAA house in order, as HIPAA is now fully enforced and the government is not using kid gloves anymore. It will also address major 2019 changes taking place with the Health and Human Services regarding the enforcement of the HIPAA law as well as detailed discussions on the Phase 2 audit process and current events regarding HIPAA cases (both in courtrooms and from real-life Audits). HIPAA Privacy, Security, and Breach Notification Audit Program: As a part of our continued efforts to assess compliance with the HIPAA Privacy, Security and Breach Notification Rules, the HHS Office for Civil Rights (OCR) has begun its next phase of audits of covered entities and their business associates. The 2016 Phase 2 HIPAA Audit Program will review the policies and procedures adopted and employed by covered entities and their business associates to meet selected standards and implementation specifications of the Privacy, Security, and Breach Notification Rules. Our Demonstrator/Counsellor - Mr. Brian Tuttle has over 20 years of extensive experience working as a Compliance auditor and has been an expert witness on multiple HIPAA cases. He`ll thoroughly put light on HOW and in WHAT scenarios patients can claim for cash remedies. More importantly, Brian will show how to limit those risks by simply taking proactive steps and utilizing best practices. Why should you listen to Counsellor? This Seminar will go over steps to take "To avoid an audit" or "To survive an audit". The Counsellor will thoroughly explain how patients can now get cash remedies for wrongful disclosures of private health information (which leads to more audits). • How Will the Audit Program Work? • Are you on the hot seat for a HIPAA audit? How do you know? • Are you prepared to protect your practice or business? • What factors might spurn a HIPAA audit? Are you doing these things? • Will Audits Differ Depending on the Size and Type of Participants? • Will Auditors Look at State-Specific Privacy and Security Rules in Addition to HIPAA's Privacy, Security, and Breach Notification Rules? It will also address major changes under the Omnibus Rule and any other applicable updates for 2019 and beyond. • Omnibus has changed the HIPAA landscape for good! • This once rarely enforced law has changed and you need to know what's going on! • Protect your practice or business! • These day's trial attorney poses a higher risk than the Federal government! • State laws are now in place increasing liability for patient remedies! • What factors might spurn a lawsuit or a HIPAA audit? - Are you doing these things? • Why are the Feds enforcing after all these years? HIPAA Title Breakdown: • History of HIPAA • HITECH • HIPAA Omnibus Rule • How to perform a HIPAA Security Risk Assessment • What is involved in a Federal audit and how is it conducted • Risk factors for a federal audit • EHR and HIPAA • Business Continuity/Disaster Recovery Planning • Business Associates and HIPAA • In depth discussions on IT down to the nuts and bolts • BYOD - Bring Your Own Device • Risk factors that can cause an audit (low hanging fruit) • New rules which grant states ability to sue citing HIPAA on behalf of a patient • New funding measures.... much, much more Who can benefit: • Practice Managers • Compliance Officers • HIPAA Officers • Any business associates privy to private health information and under the auspices of this law. • Any business associates who work with medical practices or hospitals (i.e. billing companies, transcription companies, IT companies, answering services, home health, coders, attorneys, etc) • MD's and other medical professionals. Register:https://www.compliancekey.us/seminar-details?industryId=3&seminarid=36&speakerid=30 Compliance Key Visit:https://www.compliancekey.us/upcoming-seminars Phone:717-208-8666 Email:support@compliancekey.us (Added: Mon Mar 18 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

Brian Tuttle: Total HIPAA Compliance - Double Tree by Hilton Hotel, Rosemount, Chicago, IL- March 15th 2019- Brian Tuttle is a remarkable presenter and Keynote Speaker at Compliance Key. He is a Certified Professional in Health IT (CPHIT), Certified HIPAA Professional (CHP), Certified HIPAA Administrator (CHA), Certified Business Resilience Auditor (CBRA), Certified Information Systems Security Professional (CISSP) with over 18 years' experience in Health IT and Compliance Consulting and he is well versed with immense knowledge of HIPPA. HIPAA law regulates the use and disclosure of an individual’s health information in any format, also known as Protected Health Information (PHI). Performed by CPA firm SSAE 16 Professionals, LLP, the evaluation of compliance was designed to measure the strict controls Melissa has put into place to keep customer information private and secure Brian is well known and highly regarded in medical circles throughout the United States for his quality work and down home southern charm Mr Tuttle holds a Master's Degree in Health Sciences from Georgia State University and works nationally out of Kennesaw, GA. His expertise on services include: • HIPAA Security/Privacy auditing • Comprehensive NIST based risk assessments with mitigation • HIPAA awareness training and certification • Custom written policies and procedures • Public speaking • Specialized HIPAA Training • Subject matter writing • HIPAA consulting and certification for proprietary software companies • Business continuity (Disaster Recovery) planning and consulting With vast experience in health IT systems (i.e. practice management, EHR systems, imaging, transcription, medical messaging, etc.) as well as over 18 years’ experience in standard Health IT with multiple certifications and hands-on knowledge, Brian serves as compliance consultant and has conducted onsite and remote risk assessments for over 1000 medical practices, hospitals, health departments, insurance plans, and business associates throughout the United States. Outline Synopsis This seminar will be drawing attention how practice/business managers or compliance officers need to get their HIPAA house in order, as HIPAA is now fully enforced and the government is not using kid gloves anymore. It will also address major 2019 changes taking place with the Health and Human Services regarding the enforcement of the HIPAA law as well as detailed discussions on the Phase 2 audit process and current events regarding HIPAA cases (both in courtrooms and from real-life Audits). HIPAA Privacy, Security, and Breach Notification Audit Program: As a part of our continued efforts to assess compliance with the HIPAA Privacy, Security and Breach Notification Rules, the HHS Office for Civil Rights (OCR) has begun its next phase of audits of covered entities and their business associates. The 2016 Phase 2 HIPAA Audit Program will review the policies and procedures adopted and employed by covered entities and their business associates to meet selected standards and implementation specifications of the Privacy, Security, and Breach Notification Rules. Our Demonstrator/Counsellor - Mr. Brian Tuttle has over 20 years of extensive experience working as a Compliance auditor and has been an expert witness on multiple HIPAA cases. He`ll thoroughly put light on HOW and in WHAT scenarios patients can claim for cash remedies. More importantly, Brian will show how to limit those risks by simply taking proactive steps and utilizing best practices. Why should you listen to Counsellor? This Seminar will go over steps to take "To avoid an audit" or "To survive an audit". The Counsellor will thoroughly explain how patients can now get cash remedies for wrongful disclosures of private health information (which leads to more audits). • How Will the Audit Program Work? • Are you on the hot seat for a HIPAA audit? How do you know? • Are you prepared to protect your practice or business? • What factors might spurn a HIPAA audit? Are you doing these things? • Will Audits Differ Depending on the Size and Type of Participants? • Will Auditors Look at State-Specific Privacy and Security Rules in Addition to HIPAA's Privacy, Security, and Breach Notification Rules? It will also address major changes under the Omnibus Rule and any other applicable updates for 2019 and beyond. • Omnibus has changed the HIPAA landscape for good! • This once rarely enforced law has changed and you need to know what's going on! • Protect your practice or business! • These day's trial attorney poses a higher risk than the Federal government! • State laws are now in place increasing liability for patient remedies! • What factors might spurn a lawsuit or a HIPAA audit? - Are you doing these things? • Why are the Feds enforcing after all these years? HIPAA Title Breakdown: • History of HIPAA • HITECH • HIPAA Omnibus Rule • How to perform a HIPAA Security Risk Assessment • What is involved in a Federal audit and how is it conducted • Risk factors for a federal audit • EHR and HIPAA • Business Continuity/Disaster Recovery Planning • Business Associates and HIPAA • In depth discussions on IT down to the nuts and bolts • BYOD - Bring Your Own Device • Risk factors that can cause an audit (low hanging fruit) • New rules which grant states ability to sue citing HIPAA on behalf of a patient • New funding measures.... much, much more Who can benefit: • Practice Managers • Compliance Officers • HIPAA Officers • Any business associates privy to private health information and under the auspices of this law. • Any business associates who work with medical practices or hospitals (i.e. billing companies, transcription companies, IT companies, answering services, home health, coders, attorneys, etc) • MD's and other medical professionals. Register:https://www.compliancekey.us/seminar-details?industryId=3&seminarid=36&speakerid=30 Compliance Key Visit:https://www.compliancekey.us/upcoming-seminars Phone:717-208-8666 Email:support@compliancekey.us (Added: Mon Mar 18 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

Medical Device Security Market - Medical Device Security Market is expected to propel US$ XX Bn by 2026 with a CAGR of XX% in the forecasting period 2018-2026. The medicinal gadgets are in general consistent with the checking and perceive ability across various system access leading to infringement, and vulnerabilities. The application of a managed detection and response arrangement enables to keep in track various medical devices. The market is favoured by growing adoption of wearable devices with more than US$ 800 million revenue in 2017 itself. Factors such as rise in instances of healthcare cyber-attacks and threats, along with subsequent growth in chronic disease management are a few key factors that have boosted the overall market growth. Moreover, government regulations and compliance, rise in adoption of connected medical devices, and growing application of cyber-security solutions are a few other key driving factors boosting the medical device security market. However, it is the limitations in the healthcare security budgets along with the lack of infrastructure to manage even the basic security protections that forms the key restraints for the medical device security market. The service segment is expected to hold the largest market share among other components for the medical device security market globally. Factors such as the support & maintenance services for protecting connected medical devices and protecting healthcare IT infrastructure from the growing number of cyber-attacks have acted as drivers for the growth of services segment. The Medical Device Security market is segmented by component, security, device type, end-user, and region. By device type the market is segmented into hospital medical devices, wearable medical devices, and embedded medical devices. The wearable medical devices are expected to account for one of the fastest growth rate that is because of the huge penetration of internet within the healthcare sector as well as growing adoption of receiving the real-time health information for monitoring the patients’ health. Rise in adoption of connected medical devices have also been a major factor that is driving the overall market growth for medical device security. By geography, the Medical Device Security market can be segmented into North America, Europe, Asia Pacific, Middle East, and Latin America. North America is expected to hold the largest market share chiefly driven by reasons that include increasing instances of cyber-attacks for getting confidential patient information, along with increasing awareness among healthcare professionals regarding cyber-security. Improvement in healthcare related government policies and improving healthcare infrastructure are also the chief drivers that have driven the market growth of medical device security market globally. The key players of medical device security market include Symantec (US), Cisco Systems (US), CA Technologies (US), IBM (US), GE Healthcare (US), and Philips Healthcare (Netherlands). For more information visit @https://www.maximizemarketresearch.com/market-report/medical-device-security-market-2/12496/ Medical Device Security Market scope:- Medical Device Security Market, By Component • Solution • Services o Professional o Managed Medical Device Security Market, By Security • Endpoint • Wireless • Network • Application • Cloud Medical Device Security Market, By Device Type • Hospital Medical Devices • Wearable Medical Devices • Embedded Medical Devices Medical Device Security Market, By End-user • Hospitals • Medical Device manufacturers • Others Medical Device Security Market, By Geography • North America • Europe • Asia-Pacific • Middle East & Africa • Latin America Key Players operating in the Medical Device Security Market : • GE Healthcare • Cisco Systems • Symantec Corporation • International Business Machines Corporation (IBM) • CA Technologies • Mcafee • Fortinet • Zscaler • Palo Alto Networks • Cleardata • DXC Technology • Sophos • Fireeye • Check Point Software Technologies • Cloudpassage • Koninklijke Philips N.V. • Imperva This Report Is Submitted By @Maximize Market Research Company Customization of the report: Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities. About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors. Contact info: Name: Lumawant Godage Organization: MAXIMIZE MARKET RESEARCH PVT. LTD. Email: sales@maximizemarketresearch.com Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India. Contact: +919607195908 (Added: Mon Mar 18 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

Global Medical Polymer Market - Global Medical Polymer Market was valued US$ 14.31 in 2017 and is estimated to surpass US$ 22.94 Billion mark in at a Compound Annual Growth Rate (CAGR) of 8.81 % during the forecast period 2018-2024 globally. Global Medical Polymer Market Global medical polymer market is driven by rising geriatric population and prevalence of chronic diseases, which significantly boosted demand for medical implants. In addition, medical polymer market is witnessing high growth globally owing to the high acceptance and adoption of polymers for product manufacturing. Increasing geriatric population is expected to result in the rise in healthcare facilities which is expected to drive the industry growth. This is expected to aid the growth for medical devices and therefore have a positive impact on the overall medical polymers market. Increasing bio-compatibility of plastics has also been a significant cause for the medical polymer industry growth. Medical polymer possess low weight compared to the metallic material hence are preferred for a variety of applications in medical industry. Medical grade fibers & resins will dominate the market by 2026, attributed to its superior properties such as high thermal and chemical resistance together with ease of sterilization. Fibers and resin segment accounted for the largest share in 2017 owing to high use in various applications including hip & joint replacement surgeries, spinal implants, and different injuries. While biodegradable plastics is estimated to grow at highest CAGR of 16.1% over the forecast period in terms of revenue, owing to health concerns regarding synthetic polymers. Increasing expenditure on healthcare along with the presence of well-equipped hospitals have a positive impact on hospital accessories segment growth. Increasing demand for surgical instruments and tools such as gloves, clamps, forceps, syringes, surgical trays, medical bags, and catheters is expected to drive demand for medical polymers over the forecast period. Medical polymer segment has further dominated the hospital accessories segment due to their high flexibility, low manufacturing cost, and high infection resistance compared to other metallic materials. Implants application segment held the largest market share in 2017, due to a high demand for implants for replacement surgeries such as a knee, hip, joint, and dental. Demand for implants is growing primarily due to increased incidences of chronic diseases and increasing global geriatric population. Applications such as cardio implants and devices and tissue engineering may propel the growth of the global market in the near future. Polymers are widely used in the medical sector, including diagnostic systems, implants, and accessories. Intraocular lenses, contact lenses, facial implants, vascular grafts, breast implants, catheters, dental implants, and prosthetic hearth valves are a few examples of where the medical polymers are used. North America accounted for the largest share of the medical polymer market followed by Europe, and the Asia Pacific. North America is dominant owing to increased prevalence of chronic disease, and a high transplant surgery rate. In addition, the population having a higher awareness of health benefits like low product cost and enhanced performance polymers have further boosted the overall growth. Also, the presence of major manufacturers and their well-established network in the region have also helped in the overall growth. Asia Pacific region is expected to see growth in medical polymer market during the current forecast period due to the rising awareness for low cost but advanced materials and their related benefits. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding medical polymer market dynamics, structure by identifying and analyzing the market segments and project the market size. Further, the report also focuses on a competitive analysis of key players by product, price, financial position, Purity portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER's analysis, SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in medical polymer market. For more information visit @https://www.maximizemarketresearch.com/market-report/global-medical-polymer-market/12507/ The Scope of the Global Medical Polymer Market: Global Medical Polymer Market, By Product type: • Fibres and Resins • Medical Elastomers • Biodegradable Medical Polymers Global Medical Polymer Market, By Application: • Implants • Diagnostic Systems • Hospital Accessories Global Medical Polymer Market, By Geography: • North America • Europe • Asia Pacific • Latin America • Middle East and Africa Key Players analyzed in the Report: • Eastman Chemical Company • Evonik Industries AG • The Dow Chemical Company • Formosa Plastics Corporation USA • Arkema SA • BASF SE • Covestro AG • DSM N.V. • Solvay S.A • Celanese Corporation • Victrex Plc. • DuPont • Tianjin Plastics Research Institute Co. Ltd • Lubrizol Corporation • Bayer • Celanese • Eastman Chemical • Borealis • DSM • ExxonMobil • Huizhou Foryou Medical Devices • Kraton Performance Polymers • Victrex This Report Is Submitted By @Maximize Market Research Company Customization of the report: Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities. About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors. Contact info: Name: Lumawant Godage Organization: MAXIMIZE MARKET RESEARCH PVT. LTD. Email: sales@maximizemarketresearch.com Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India. Contact: +919607195908 (Added: Mon Mar 18 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

Recently transferred one Pneumonia Child by Commercial Vedanta Air Ambulance from Guwahati - Over 81 percent of deaths from pneumonia are in children under two years old, but these deaths are broadly avoidable. Researchers estimate that the vast majority of these belongings could be prevented by vaccines, and were mainly caused by malnutrition, sub-optimal breastfeeding, and zinc deficiency. Recently our team transferred one Child from Guwahati to Vellore and he was suffering from pneumonia and his condition was quite serious. Highly Equipped Air Ambulance Service- Vedanta Air Ambulance Since its inception, it has been giving full hold up to the family members of the patient and helps them with possible things. Even if the family members need any kind of VISA support, our staffs will help them in getting that. Whenever any member of the patient asks our workers whatever thing, they will listen to them very cautiously and forward their hands to help them. They are very friendly and helpful. They indulgence the patient not as their customer but as a family member. This is what the people of Kolkata prefer to choose Vedanta Air ambulance service fare. How to transfer the patient from Guwahati to Vellore, Delhi, Mumbai or Chennai? This is the question generally comes in mind. We will provide you service from your patient hospital to your purpose hospital or residence with full ICU setup tackle and totally bed to bed service. We provide these advanced facilities: Bed to Bed transfer Service Scoop Stretchers, Wheel Chairs, and Medical Beds Certified, Confirmed and Approved Medical Health Care Dispatchers No Unseen Cost, Extra Demanding and Any Additional Burden for Air Ambulance Air Ambulance from Guwahati cost is not so high we prefer low-cost and reasonable fare service to the guest. This Air Ambulance is one of the advance, best and innovative Air Ambulance Service contributor by rather each and every ICU or CCU equipment like- portable and hi-tech ventilator, suction machine, infusion pump, nebulizer machine, oxygen cylinders, pacemakers, defibrillator and the entire life rescuing stocks; those all the well-versed and well-occupied and emergency familiar equipment are operated by the long-time knowledgeable and highly qualified MD doctors, skilled paramedical technicians, expert medical staffs and airlifted assistances from one point to another point. Air Ambulance from Mumbai prefers 24/7 Hours Non-stoppage and incessant Emergency Services of Air Ambulance Service we prefer totally transparent and quality approved bed to bed medical transfer services from one to another city. Web@ https://www.vedantaairambulance.com/air-ambulance-in-guwahati/ More@ https://www.vedantaairambulance.com/air-ambulance-in-mumbai/ (Added: Mon Mar 18 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

Food Colors Market - Food Colors Market is expected to reach US$ XX Bn by 2026, growing at a CAGR of XX% during the forecast period. Increase in universal population is expected to result in a huge demand for food & beverage products, which will drive the demand for the food product during the forecast period. Food Colors are the substance which imparts color when it is added to food. Food Colors come in various forms like liquids, powders, gels, and pastes. Food colors are used in commercial food production as well as in domestic cooking. Food colorants are used in different non-food applications. Applications include cosmetics, pharmaceuticals, home craft projects, and medical devices. Food Colors Market Food Colors Market is segmented by Type, Application, and Geography. The increasing knowledge about food products with colorful & traditional taste will drive the market in the next few years. The demand for natural food colors is increasing at a global level. Many health profits related to their consumption are key factors to increase demand for natural color during the forecast period. Food with a natural color is growing worldwide, due to growing health awareness, the increasing spending power of customers. Food Colors Market Based on application Non-dairy food will hold the largest market share during the forecast period due to growing usage of food colors in the food industry to improve the aesthetics demand of the product. Europe is expected to be the largest market for food colors during the forecast period owing to the increasing awareness of safe food products among customers, and strict food safety regulations in the region. Germany is one of the leading processed food markets with strict regulations to keep a check on the quality of food products. Key Players 1. Chr. Hansen S/A 2. Sensient Technology Corporation 3. Koninklijke DSM N.V. 4. Archer Daniels Midland Company 5. FMC Corporation 6. D.D. Williamson & Co. Inc. 7. Naturex S.A. (DDW) 8. Fiorio Colori 9. Döhler Group 10. Kalsec Inc. 11. ADM 12. Dowdupont 13. DSM 14. Döhler Group 15. Frutarom 16. Lycored For more information visit @https://www.maximizemarketresearch.com/market-report/food-colors-market/12515/ Scope of the Food Colors Market : Food Colors Market, by Type: Natural, Synthetic Food Colors Market, by Application: Dairy Food, Non Dairy Food, Non Alcoholic Beverages, Alcoholic Beverages Food Colors Market, by Geography: North America, Europe, Asia Pacific, Middle East & Africa and Latin America This Report Is Submitted By @Maximize Market Research Company Customization of the report: Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities. About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors. Contact info: Name: Lumawant Godage Organization: MAXIMIZE MARKET RESEARCH PVT. LTD. Email: sales@maximizemarketresearch.com Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India. Contact: +919607195908 (Added: Mon Mar 18 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

Are You Using These Pipes For Your Projects? - Well, which is one of the fantastic moves you switch with, when it comes to choosing selective pipe for all your projects as needed and required? Do you have any selections, though? Is it ERW Pipe, or GI Pipe? Let’s move further: Can it be MS Pipe at the same time? If not, then you should be choosing them for sure. So, today in the post itself, we will be ensuring that you learn basics about these pipes and make sure to get them for all your projects upon your needs. P.S. Are you looking for the ERW Pipe supplier in India? Do you have any requirement of any such pipe because you want your project to be sustained as well as remarkable, meaning more reputation in the marketplace as well as easily domination over competitors? If yes, there’s where Tube Trading comes into the picture. If you need MS Pipe, GI Pipe or ERW Pipe, they will stand firm on your requirement and cater their services accordingly. So, it will be great if you contact them today for your entire requirement at the same time. The best part is – They are the supplier, manufacturer as well as distributor of these pipes. So, without any further ado, let’s get started to learning about these pipes at the same time! Use of MS Pipe: It stands for Mild Steel Pipe. Such pipes are often used in industrial as well as domestic usage. From chassis, steering, tools and parts of automobile industry to chairs, table, racks and storage system, you can always look your way to MS Pipe exponentially. Use of GI Pipe: GI Pipes are often used in larger industrial construction projects because of low cost piping solution as well as low maintenance cost at the quickest. Such pipes are quite rugged as well as long lasting, meaning you can use them as required and needed in the projects. Use of ERW Pipe: ERW Pipes are widely used in various purposes namely structural and engineering industry for their effectiveness and sustainability. ERW Pipes stands for Electric Resistance Welded Pipes, and is always taken into account for fencing, line pipes as well as scaffolding. Final Thoughts What do you think about the blog post shared? Is there anything we missed? Please do share and let us know your opinions, so community will learn and explore about the subject matter to the greatest degree possible! (Added: Mon Mar 18 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

Cardiac Pacemakers Market - Cardiac Pacemakers Market is estimated to reach US$ XX Mn by 2026 in terms of revenue at a CAGR of XX % in the forecast Period. A pacemaker is a medical device that generates electrical pulses delivered by electrodes to contract the heart muscles and regulate the electrical conduction system of the heart. The increasing prevalence of atrial fibrillation (AFib), growing geriatric population, and rising health care expenditures are triggering the growth of Cardiac Pacemakers Market. The growing prevalence of rising geriatric population coupled with the increasing predominance of cardiovascular diseases, favorable reimbursement scenario, technological advancement in cardiac pacemakers systems and entry of new players drive the growth of the Cardiac Pacemakers Market. However, the high cost of the pacemakers followed by the need for surgery and risks of dysfunctioning associated with cardiac pacemakers will restrain the market growth during the forecast period. Cardiac pacemakers market is majorly segmented by product type, technology, and geography. Based on product type, the market is segmented into the implantable cardiac pacemaker and external cardiac pacemaker. The implantable cardiac pacemaker is expected to grow at the highest CAGR during the forecast period. This can be attributed to the presence of multiple leads, which enable the normal physiological functioning of the heart, resulting in fewer post-operative complications. on Technology, the Global Cardiac Pacemakers Market is segmented into single chambered, dual chambered, and biventricular. The single-chambered segment is expected to grow at the highest CAGR during the forecast period. The high growth of the segment can be mostly attributed to the large advanced technology and favorable reimbursements for cardiac pacemaker surgery treatment in developed countries. The North America region in the cardiac pacemakers market holds a major market share and is primarily driven by factors such as the rise in the incidences of hypertension. High cholesterol and diabetes have resulted in the increase of cardiovascular diseases in the region. The Asia-Pacific region is expected to witness a significant growth during the forecast period as compared to the developed markets due to the huge patient pool with chronic diseases and increasing healthcare expenditure. Several government initiatives are anticipated to create a free and open economy. Also, recently introduced economic reforms in China, promoting a well-balanced and open economy will have a significant impact in shaping the fortune of the market. Cardiac Pacemakers Market share is consolidated, as the key multinational players occupy the major industry share. Medtronic’s, St.Jude Medical Inc., Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Lepu Medical Technology Co ltd., MEDICOWEB, Pacetronix ltd., LivaNova Plc., and Osypka Medical GmbH. are some of the major industry players. Medtronic, a leading player, has gained a high market share due to its diverse product range in cardiac pacemakers. The Medtronic Company is well established and enjoys a prominent presence in the market. Production capacity expansion, brand portfolio expansion, mergers, collaborations, and acquisitions are the key strategies adopted by industry players. For more information visit @https://www.maximizemarketresearch.com/market-report/cardiac-pacemakers-market/12522/ The Scope of the Cardiac pacemakers market Report Scope: The market covered in this report has been segmented as follows: • Global Cardiac Pacemakers Market, by Product Type o Implantable cardiac pacemaker o External cardiac pacemaker • Global Cardiac Pacemakers Market, by Technology o Single chambered o Dual chambered o Biventricular • Global Cardiac Pacemakers Market, by Geography o North America o Europe o Asia Pacific o Rest of the World Key Players operating in the Global Cardiac Pacemakers Market: • Medtronic’s • St.Jude Medical Inc. • Boston Scientific Corporation • BIOTRONIK SE & Co. KG • Lepu Medical Technology Co Ltd. • MEDICOWEB • Pacetronix ltd. • LivaNova Plc. • Osypka Medical GmbH. This Report Is Submitted By @Maximize Market Research Company Customization of the report: Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities. About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors. Contact info: Name: Lumawant Godage Organization: MAXIMIZE MARKET RESEARCH PVT. LTD. Email: sales@maximizemarketresearch.com Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India. Contact: +919607195908 (Added: Mon Mar 18 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

Yoga Teacher Training in Rishikesh,India - Everyone on this earth planet wants to lead a happy and healthy life. There could be various ways to gain physical health, but the only way to grab physical and mental health is yoga. With the help of yoga exercises, you will not only achieve physical fitness but also be able to touch highest level of consciousness. JeevMokshaYoga training institute has introduced a plethora of different types of yoga courses in India. You can choose a right one keeping your needs in mind. Do you want to know more about yoga teacher training and courses in India? If yes, then visiting at jeevmokshayoga can help you great. “Modern people find it difficult to lead a happy life due to physical problems and psychological issues. Therefore, we at Jeev Moksha Yoga decided to help modern people through our ancient yoga techniques. Now, we are happy to introduce effective yoga courses for modern individuals”, an official spokesperson said in the media brief. “We haven’t established this platform to make money, but our sole purpose of establishing this ancient system of offering yoga courses in India is to help people gaining desired level of physical, mental and spiritual realms”, he further added. Having gone through aforesaid statement, it can be concluded that it is a truth. This is surely the key reason why despite of so many yoga schools in India, most of the domestic and international students prefer choosing Jeev Moksha Yoga as their best yoga schools in India. This yoga institute is surrounded by lush greenery in Rishikesh. There is no doubt that Rishikesh is among the most visited hill stations in the country. Practicing yoga of different forms in the lap of nature simply enhances the power in you. You can be able to rediscover new dimensions of consciousness. “We have a team of yoga instructors or teachers who are always ready to help our students. Since experience is everything when it comes to effectiveness of yoga, we have joined hands with top yoga teachers in India to help global students in achieving desired level of physical, psychological and spiritual goals”, spokesperson at the institute explained in a press conference. “We aren’t an ordinary yoga teacher training Rishikesh, but we have an exceptional record of helping people understanding the realities of different yoga exercises – from simple posture yoga to hardcore hatha yoga”, he further clarified. There is no doubt that grabbing right education is needed if you want to accomplish desired results. The same rule can also be applicable when it comes to choosing yoga courses in India. You need to choose a yoga course that can easily cater your goals of achieving spiritual, mental and physical excellence. Are you looking for the best yoga schools in India? Do you want to practice hatha yoga? Do you want to get rid of psychological trap? Do you want to lead a happy life? If yes, then you must visit at (Added: Mon Mar 18 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

Yoga Teacher Training in Rishikesh,India - Everyone on this earth planet wants to lead a happy and healthy life. There could be various ways to gain physical health, but the only way to grab physical and mental health is yoga. With the help of yoga exercises, you will not only achieve physical fitness but also be able to touch highest level of consciousness. JeevMokshaYoga training institute has introduced a plethora of different types of yoga courses in India. You can choose a right one keeping your needs in mind. Do you want to know more about yoga teacher training and courses in India? If yes, then visiting at jeevmokshayoga can help you great. “Modern people find it difficult to lead a happy life due to physical problems and psychological issues. Therefore, we at Jeev Moksha Yoga decided to help modern people through our ancient yoga techniques. Now, we are happy to introduce effective yoga courses for modern individuals”, an official spokesperson said in the media brief. “We haven’t established this platform to make money, but our sole purpose of establishing this ancient system of offering yoga courses in India is to help people gaining desired level of physical, mental and spiritual realms”, he further added. Having gone through aforesaid statement, it can be concluded that it is a truth. This is surely the key reason why despite of so many yoga schools in India, most of the domestic and international students prefer choosing Jeev Moksha Yoga as their best yoga schools in India. This yoga institute is surrounded by lush greenery in Rishikesh. There is no doubt that Rishikesh is among the most visited hill stations in the country. Practicing yoga of different forms in the lap of nature simply enhances the power in you. You can be able to rediscover new dimensions of consciousness. “We have a team of yoga instructors or teachers who are always ready to help our students. Since experience is everything when it comes to effectiveness of yoga, we have joined hands with top yoga teachers in India to help global students in achieving desired level of physical, psychological and spiritual goals”, spokesperson at the institute explained in a press conference. “We aren’t an ordinary yoga teacher training Rishikesh, but we have an exceptional record of helping people understanding the realities of different yoga exercises – from simple posture yoga to hardcore hatha yoga”, he further clarified. There is no doubt that grabbing right education is needed if you want to accomplish desired results. The same rule can also be applicable when it comes to choosing yoga courses in India. You need to choose a yoga course that can easily cater your goals of achieving spiritual, mental and physical excellence. Are you looking for the best yoga schools in India? Do you want to practice hatha yoga? Do you want to get rid of psychological trap? Do you want to lead a happy life? If yes, then you must visit at (Added: Mon Mar 18 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

Follicular Lymphoma Treatment Market - Follicular Lymphoma Treatment Market is expected to reach US$ XX Bn by 2026 from US$ XX Bn in 2017 at a CAGR of XX% Lymphoma is cancer of lymphatic system, which disturbs the cells of the immune system known as lymphocytes causes’ growth of the cells. Lymphocytes are the white blood cells which protect the body from the infection. It is of two types one is Non-Hodgkin and another is Hodgkin lymphoma. Follicular lymphoma is a type of Non-Hodgkin Lymphoma which affects the lymphocytes. Follicular lymphoma has symptoms like increase of the lymph nodes in the neck, shortness of breath, weight loss, night sweats. The rising prevalence of follicular lymphoma, family history of the disease, and increasing incidence of blood disorders worldwide are proving to be the key driving factors for Follicular Lymphoma Treatment Market. In addition, increasing research and development activities for the innovation of newer drugs and treatment methods and technological advancements in disease diagnosis would further fuel the follicular lymphoma market in the near future. However, the probable restraints like strict regulatory requirements for drug approval, high treatment cost, and adverse effects associated with different treatment methods should also be taken into account. Follicular Lymphoma Treatment Market Follicular Lymphoma Treatment Market is segmented by Treatment Type, End User, and Geography. The key factors which drive the global follicular lymphoma treatment market in the forecast period are increasing the occurrence of follicular lymphoma, Genetic disease, and growth rate of blood disorders at a global level. However, firm regulatory requirements for drug approval, huge treatment cost, and adverse results related to different treatment methods may restrain the market. Furthermore, new therapies like monoclonal antibodies with government initiatives for cancer management are expected to boost the market. Radiation and chemotherapy are currently a reactive treatment for follicular lymphoma. However, radiation alone is used for the treatment of follicular lymphoma in maximum cases. In complex cases, chemotherapy alone is used for the treatment of follicular lymphoma. Moreover, Targeted Therapy is better than chemotherapy and Radiation, as they act directly by targeting tumour cells. Geographically North America follicular lymphoma treatment market is is expected to hold maximum market share during forecast period huge growth in the occurrence of the disease in the region, mainly in the U.S. The market in Europe is also expected to expand significantly during the estimated period, because of firm health care infrastructure and rise in the occurrence of follicular lymphoma in the region. Some of the important players working at a global level contain Roche, Spectrum Pharmaceuticals, Johnson and Johnson, CTI Biopharma, Celgene, AbbVie Inc., Novartis, Amgen, Merck & Co. (MRK), Seattle Genetics, Pharmacyclics/ Bristol-Myers Squibb (BMY), and Bayer AG’S. In 2017, Bayer AG’s has launched the advanced drug, Aliqopa, also known as copanlisib, which is a kinase inhibitor which block certain enzymes responsible in cell growth. For more information visit @https://www.maximizemarketresearch.com/market-report/follicular-lymphoma-treatment-market/12594/ Key Players in Follicular Lymphoma Treatment Market 1. AG 2. Seattle Genetics 3. Spectrum Pharmaceuticals 4. Celgene 5. Millennium/Johnson-Johnson 6. Merck 7. Pharmacyclics/Janssen Biotech 8. Kyowa Hakko Kirin 9. CTI Biopharm 10. Altor BioScience Corporation 11. Amgen Inc. 12. Astellas Pharma Inc. 13. Bayer AG 14. Boehringer Ingelheim GmbH 15. Roche 16. Spectrum Pharmaceuticals 17. Johnson and Johnson 18. CTI Biopharma 19. Celgene 20. AbbVie Inc 21. Novartis 22. Amgen Scope of the Follicular Lymphoma Treatment Market: Follicular Lymphoma Treatment Market, Treatment Type : ( Radiation, Targeted Therapy, and Chemotherapy) Follicular Lymphoma Treatment Market End User : ( Hospitals, Clinics, and Cancer Research Institutes) Follicular Lymphoma Treatment Market, by Geography: (North America, Europe, Asia Pacific, Middle East & Africa and Latin America) This Report Is Submitted By @Maximize Market Research Company Customization of the report: Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities. About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors. Contact info: Name: Lumawant Godage Organization: MAXIMIZE MARKET RESEARCH PVT. LTD. Email: sales@maximizemarketresearch.com Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India. Contact: +919607195908 (Added: Mon Mar 18 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

Central Coast YMCA Diabetes Alert Day March 26, 2019 - The CENTRAL COAST YMCA announces Diabetes Alert Day 2019. Together we can Build a better us. Monterey, San Benito & Santa Cruz Counties, CA, March 17, 2019 - Tuesday, March 26, is American Diabetes Association Alert Day®. According to current CDC statistics, 1 out of 3 U.S. adults has prediabetes and only 10% know they have it. The CENTRAL COAST YMCA is encouraging people in our community to learn the risks of prediabetes and type 2 diabetes and steps they can take to prevent the disease. Starting March 25 through March 28, each of our branch locations will host an informational booth on Diabetes and Prediabetes. Learn about our Diabetes Prevention Program (DPP) which helps participants reduce their risk for type 2 diabetes through lifestyle changes that include healthy eating and physical activity. Anyone age 18 and over with a diagnosis of pre-diabetes is eligible for this year-long program with approval from their physician. DPP is a nationally recognized program, originated by the CDC. Research by the National Institute of Health has shown that programs like the YMCA’s DPP can reduce the number of new cases of type 2 diabetes by 58 percent, and 71 percent in adults over the age of 60. South County YMCA Monday, March 25th 10:30am – 11:30am Salinas YMCA Tuesday March 26th 9:00am – 11:00am Tuesday March 26th 6:00pm – 7:30pm Watsonville YMCA Wednesday, March 27th 9:00am – 11:30am San Benito YMCA Wednesday, March 27th 10:30am – 11:30am Monterey YMCA Thursday, March 28th 10:30am – 11:30am More details are available at each of our branch locations and on-line at www.centralcoastymca.org. Or contact Bill Proulx at 831-757-4633 or bproulx@centralcoastymca.org. About the Y The Central Coast YMCA was formed in 1989 with the merger of two independent YMCAs: the Salinas Community YMCA (founded in 1921) and the Watsonville Family YMCA (founded in 1898). The YMCA of the Monterey Peninsula, which began as a USO in 1941, merged with the Central Coast YMCA in 1990. The South County YMCA became the fourth branch of the Central Coast YMCA in 1998 and the YMCA of San Benito County followed as the fifth branch in 1999. Today, the Central Coast YMCA employs 30 full-time and about 375 part-time employees whose goal is to serve approximately 30,000 people within Santa Cruz, San Benito and Monterey counties. Contact: Marci Bracco Cain Chatterbox PR Salinas, CA 93901 (831) 747-7455 http://www.centralcoastymca.org (Added: Sun Mar 17 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

Dr. Mihir Bapat Spine Surgeon Hospital Mumbai, India - Dr. Mihir Bapat is a highly renowned spine surgeon in Mumbai, India, recently reached a milestone as he performed his 500th Oblique Lateral Lumber Interbody Fusion (OLLIF) on a patient at Nanavati Hospital Mumbai. The OLLIF process represents medicines’s cutting-edge advancements in minimally invasive spine surgery. It treats the various indications that results in back pain, inclusive of: degenerative disc sickness, herniated discs, spondylolisthesis, scoliosis, and spinal stenosis. An OLLIF procedure is often required when a disc is damaged or is degenerated. Generally, the height of the disc is reduced, unstable, and bulging. This condition, in turn, can positioned pressure on the nerves exiting the backbone and can cause extreme pain in the legs and back. According to Dr. Bapat top minimally invasive spine surgeon in Mumbai, that stabbing, crippling pain has been described as worse than childbirth by several of his patients. As people age, their discs become less elastic and are less able to stay in top working condition. OLLIF is intended to reestablish the height of the disc, reduce movement of the disc and alleviate pain. Compared to traditional spinal fusion procedures, OLLIF is a much less invasive surgical technique that does not require removal of any bone or ligament structures. An OLLIF procedure only requires a skin incision of 15 millimeters – smaller than a dime. The diseased disc is removed through a small portal that protects the skin, muscles and nerves. After the disc is removed and the bone graft material is placed, an implant is positioned in the disc space. The implant maintains the spacing of the vertebrae even as the fusion takes place. After the fusion is complete, solid bone mass forms and the two vertebrae are joined together. OLLIF is groundbreaking by today’s standards and revolutionary compared to the 1950s when physicians would remove a piece of the patient’s hip bone and go through their abdomen to place the hip bone piece inside the disc space to lift the spine and take pressure off the nerve. It often took patients six months to fully recover from the surgery, leaving muscles week from the long period of nonuse. A surgery that used to require seven or eight hours is now frequently performed as an outpatient procedure. OLLIF patients are often up and walking with assistance before a patient undergoing traditional open spine surgery would even be out of surgery. Hospital stays that were often up to five days in length are a thing of the past as well. Many patients receiving OLLIF have returned to work in just a few days. Of his milestone 500th OLLIF procedure, Dr. Mihir Bapat shared: “My proudest moment was to see that patient walk two hours after surgery, and then go home the next day making jokes with staff and feeling pain free for the first time in years.″ Dr. Mihir Bapat completed his MBBS from the prestigious King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College in the year 1996. He also did his MS in Orthopaedics in the year 1999 from the same institute. He was also the recipient of the Best Resident Award in 1999, while he was doing his medical residency in King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College. He is currently working in Nanavati Super Specialty Hospital. Dr. Mihir has done over 1000 spine surgeries at Kokilaben health hospital. He has special interest in degenerative disorders of the lumbar and cervical spine, scoliosis and pediatric deformity and minimally invasive spine surgery. The complication rate at <2% (benchmark 3%-5%) is extraordinarily low leading to high excessive patient satisfaction rate. For more information on OLLIF, visit website: https://www.spineandneurosurgeryhospitalindia.com/dr-mihir-bapat-top-minimally-invasive-spine-surgeon-mumbai-india.html (Added: Sat Mar 16 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

Dr. Mihir Bapat Spine Surgeon Hospital Mumbai, India - Dr. Mihir Bapat is a highly renowned spine surgeon in Mumbai, India, recently reached a milestone as he performed his 500th Oblique Lateral Lumber Interbody Fusion (OLLIF) on a patient at Nanavati Hospital Mumbai. The OLLIF process represents medicines’s cutting-edge advancements in minimally invasive spine surgery. It treats the various indications that results in back pain, inclusive of: degenerative disc sickness, herniated discs, spondylolisthesis, scoliosis, and spinal stenosis. An OLLIF procedure is often required when a disc is damaged or is degenerated. Generally, the height of the disc is reduced, unstable, and bulging. This condition, in turn, can positioned pressure on the nerves exiting the backbone and can cause extreme pain in the legs and back. According to Dr. Bapat top minimally invasive spine surgeon in Mumbai, that stabbing, crippling pain has been described as worse than childbirth by several of his patients. As people age, their discs become less elastic and are less able to stay in top working condition. OLLIF is intended to reestablish the height of the disc, reduce movement of the disc and alleviate pain. Compared to traditional spinal fusion procedures, OLLIF is a much less invasive surgical technique that does not require removal of any bone or ligament structures. An OLLIF procedure only requires a skin incision of 15 millimeters – smaller than a dime. The diseased disc is removed through a small portal that protects the skin, muscles and nerves. After the disc is removed and the bone graft material is placed, an implant is positioned in the disc space. The implant maintains the spacing of the vertebrae even as the fusion takes place. After the fusion is complete, solid bone mass forms and the two vertebrae are joined together. OLLIF is groundbreaking by today’s standards and revolutionary compared to the 1950s when physicians would remove a piece of the patient’s hip bone and go through their abdomen to place the hip bone piece inside the disc space to lift the spine and take pressure off the nerve. It often took patients six months to fully recover from the surgery, leaving muscles week from the long period of nonuse. A surgery that used to require seven or eight hours is now frequently performed as an outpatient procedure. OLLIF patients are often up and walking with assistance before a patient undergoing traditional open spine surgery would even be out of surgery. Hospital stays that were often up to five days in length are a thing of the past as well. Many patients receiving OLLIF have returned to work in just a few days. Of his milestone 500th OLLIF procedure, Dr. Mihir Bapat shared: “My proudest moment was to see that patient walk two hours after surgery, and then go home the next day making jokes with staff and feeling pain free for the first time in years.″ Dr. Mihir Bapat completed his MBBS from the prestigious King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College in the year 1996. He also did his MS in Orthopaedics in the year 1999 from the same institute. He was also the recipient of the Best Resident Award in 1999, while he was doing his medical residency in King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College. He is currently working in Nanavati Super Specialty Hospital. Dr. Mihir has done over 1000 spine surgeries at Kokilaben health hospital. He has special interest in degenerative disorders of the lumbar and cervical spine, scoliosis and pediatric deformity and minimally invasive spine surgery. The complication rate at <2% (benchmark 3%-5%) is extraordinarily low leading to high excessive patient satisfaction rate. For more information on OLLIF, visit website: https://www.spineandneurosurgeryhospitalindia.com/dr-mihir-bapat-top-minimally-invasive-spine-surgeon-mumbai-india.html (Added: Sat Mar 16 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

Dr. Mihir Bapat Spine Surgeon Hospital Mumbai, India - Dr. Mihir Bapat is a highly renowned spine surgeon in Mumbai, India, recently reached a milestone as he performed his 500th Oblique Lateral Lumber Interbody Fusion (OLLIF) on a patient at Nanavati Hospital Mumbai. The OLLIF process represents medicines’s cutting-edge advancements in minimally invasive spine surgery. It treats the various indications that results in back pain, inclusive of: degenerative disc sickness, herniated discs, spondylolisthesis, scoliosis, and spinal stenosis. An OLLIF procedure is often required when a disc is damaged or is degenerated. Generally, the height of the disc is reduced, unstable, and bulging. This condition, in turn, can positioned pressure on the nerves exiting the backbone and can cause extreme pain in the legs and back. According to Dr. Bapat top minimally invasive spine surgeon in Mumbai, that stabbing, crippling pain has been described as worse than childbirth by several of his patients. As people age, their discs become less elastic and are less able to stay in top working condition. OLLIF is intended to reestablish the height of the disc, reduce movement of the disc and alleviate pain. Compared to traditional spinal fusion procedures, OLLIF is a much less invasive surgical technique that does not require removal of any bone or ligament structures. An OLLIF procedure only requires a skin incision of 15 millimeters – smaller than a dime. The diseased disc is removed through a small portal that protects the skin, muscles and nerves. After the disc is removed and the bone graft material is placed, an implant is positioned in the disc space. The implant maintains the spacing of the vertebrae even as the fusion takes place. After the fusion is complete, solid bone mass forms and the two vertebrae are joined together. OLLIF is groundbreaking by today’s standards and revolutionary compared to the 1950s when physicians would remove a piece of the patient’s hip bone and go through their abdomen to place the hip bone piece inside the disc space to lift the spine and take pressure off the nerve. It often took patients six months to fully recover from the surgery, leaving muscles week from the long period of nonuse. A surgery that used to require seven or eight hours is now frequently performed as an outpatient procedure. OLLIF patients are often up and walking with assistance before a patient undergoing traditional open spine surgery would even be out of surgery. Hospital stays that were often up to five days in length are a thing of the past as well. Many patients receiving OLLIF have returned to work in just a few days. Of his milestone 500th OLLIF procedure, Dr. Mihir Bapat shared: “My proudest moment was to see that patient walk two hours after surgery, and then go home the next day making jokes with staff and feeling pain free for the first time in years.″ Dr. Mihir Bapat completed his MBBS from the prestigious King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College in the year 1996. He also did his MS in Orthopaedics in the year 1999 from the same institute. He was also the recipient of the Best Resident Award in 1999, while he was doing his medical residency in King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College. He is currently working in Nanavati Super Specialty Hospital. Dr. Mihir has done over 1000 spine surgeries at Kokilaben health hospital. He has special interest in degenerative disorders of the lumbar and cervical spine, scoliosis and pediatric deformity and minimally invasive spine surgery. The complication rate at <2% (benchmark 3%-5%) is extraordinarily low leading to high excessive patient satisfaction rate. For more information on OLLIF, visit website: https://www.spineandneurosurgeryhospitalindia.com/dr-mihir-bapat-top-minimally-invasive-spine-surgeon-mumbai-india.html (Added: Sat Mar 16 2019 Hits: 24 Rating: 0.00 Votes: 0) Rate It

Dr. Mihir Bapat Spine Surgeon Hospital Mumbai, India - Dr. Mihir Bapat is a highly renowned spine surgeon in Mumbai, India, recently reached a milestone as he performed his 500th Oblique Lateral Lumber Interbody Fusion (OLLIF) on a patient at Nanavati Hospital Mumbai. The OLLIF process represents medicines’s cutting-edge advancements in minimally invasive spine surgery. It treats the various indications that results in back pain, inclusive of: degenerative disc sickness, herniated discs, spondylolisthesis, scoliosis, and spinal stenosis. An OLLIF procedure is often required when a disc is damaged or is degenerated. Generally, the height of the disc is reduced, unstable, and bulging. This condition, in turn, can positioned pressure on the nerves exiting the backbone and can cause extreme pain in the legs and back. According to Dr. Bapat top minimally invasive spine surgeon in Mumbai, that stabbing, crippling pain has been described as worse than childbirth by several of his patients. As people age, their discs become less elastic and are less able to stay in top working condition. OLLIF is intended to reestablish the height of the disc, reduce movement of the disc and alleviate pain. Compared to traditional spinal fusion procedures, OLLIF is a much less invasive surgical technique that does not require removal of any bone or ligament structures. An OLLIF procedure only requires a skin incision of 15 millimeters – smaller than a dime. The diseased disc is removed through a small portal that protects the skin, muscles and nerves. After the disc is removed and the bone graft material is placed, an implant is positioned in the disc space. The implant maintains the spacing of the vertebrae even as the fusion takes place. After the fusion is complete, solid bone mass forms and the two vertebrae are joined together. OLLIF is groundbreaking by today’s standards and revolutionary compared to the 1950s when physicians would remove a piece of the patient’s hip bone and go through their abdomen to place the hip bone piece inside the disc space to lift the spine and take pressure off the nerve. It often took patients six months to fully recover from the surgery, leaving muscles week from the long period of nonuse. A surgery that used to require seven or eight hours is now frequently performed as an outpatient procedure. OLLIF patients are often up and walking with assistance before a patient undergoing traditional open spine surgery would even be out of surgery. Hospital stays that were often up to five days in length are a thing of the past as well. Many patients receiving OLLIF have returned to work in just a few days. Of his milestone 500th OLLIF procedure, Dr. Mihir Bapat shared: “My proudest moment was to see that patient walk two hours after surgery, and then go home the next day making jokes with staff and feeling pain free for the first time in years.″ Dr. Mihir Bapat completed his MBBS from the prestigious King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College in the year 1996. He also did his MS in Orthopaedics in the year 1999 from the same institute. He was also the recipient of the Best Resident Award in 1999, while he was doing his medical residency in King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College. He is currently working in Nanavati Super Specialty Hospital. Dr. Mihir has done over 1000 spine surgeries at Kokilaben health hospital. He has special interest in degenerative disorders of the lumbar and cervical spine, scoliosis and pediatric deformity and minimally invasive spine surgery. The complication rate at <2% (benchmark 3%-5%) is extraordinarily low leading to high excessive patient satisfaction rate. For more information on OLLIF, visit website: https://www.spineandneurosurgeryhospitalindia.com/dr-mihir-bapat-top-minimally-invasive-spine-surgeon-mumbai-india.html (Added: Sat Mar 16 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

Glycated Hemoglobin Testing Market - Increasing Uptake for Laboratory Based Tests to Drive Demand - Advancements in the field of diagnostics have come a long way in enabling medical professionals to enhance the lives of chronically-ill patients. Increasing incidence of diabetes around the world has spiked the use of diagnostic methods such as glycated hemoglobin tests. Manufacturers of medical devices are actively focusing on creating new products that serve the critical purpose of glycated hemoglobin testing in the diagnosis of diabetes. An exclusive research report by Transparency Market Research reveals that the growing incidence of diabetes will continue to drive the growth of the global glycated hemoglobin testing market in the foreseeable future. Report Overview: https://www.transparencymarketresearch.com/glycated-hemoglobin-testing-market.html According to the study, the global market for glycated hemoglobin testing will be worth US$ 705 million by the end of 2026. The report projects that improvements in the techniques and increasing preference of diabetics towards early diagnosis will drive the adoption of glycated hemoglobin testing in the near future. During the forecast period, 2017-2026, the global glycated hemoglobin testing market is anticipated to expand robustly at a CAGR of 8.8%. Key findings from the research study reveal that the demand for glycated hemoglobin testing services is the highest in the US and Canada. Consumers in North America are highly prone to diabetes as their proactive lifestyles and hectic professions lead them towards unhealthy diets. In 2017, North America glycated hemoglobin testing market is anticipated to be worth US$ 113 million. During the forecast period, the demand for glycated hemoglobin testing in Europe and the Asia-Pacific excluding Japan region is also expected to gain considerable traction. Patients seeking glycated hemoglobin testing are growing more inclined towards laboratory based tests. While point-of-care glycated hemoglobin testing is more convenient option, the results and diagnostic outcomes of laboratories continue to spearhead their dominance in the global market. By the end of 2026, nearly US$ 500 million worth of glycated hemoglobin tests will be performed in laboratories. However, during the forecast period, point-of-care tests are anticipated to record fastest revenue growth at a CAGR of 10.6%. Perceive the Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=35429 The report further reveals that hospitals will be the largest end-users of glycated hemoglobin testing in the global market. Through 2026, over one-third share of revenues procured in the global glycated hemoglobin testing market will be accounted by their end-use in hospitals. Diagnostic centers will also be leading end-users of glycated hemoglobin testing, while academic institutes will exhibit moderate traction in terms of adoption. On the basis of techniques, the global market for glycated hemoglobin testing will witness near-equal revenue share from chromatography and immunoassay techniques. With respect to identifying the average concentration of plasma glucose in blood, these techniques are equally effective and affordable. By 2026, revenues accounted by chromatography and immunoassays will individually bring in more than US$ 315 million to the global market value. Several manufacturers of medical devices across the globe have deeply invested in the expansion of the global glycated hemoglobin testing market. In the view of growing contribution of diabetes to revenues of pharmaceutical companies and medical device manufacturers, the overall glycated hemoglobin testing market is likely to remain lucrative in the healthcare sector. Companies namely, Arkray, Bayer, Bio-Rad Laboratories, Ceragem Medisys, Chek Diagnostics, Daiichi Biotech, DiaSys Diagnostic Systems, Diazyme Laboratories, EKF Diagnostics, Erba Mannheim, Human Diagnostics, Lite-On Technology, Menarini, Mindray Medical, Randox Laboratories, Sebia, Siemens Healthcare, TaiDoc Technology, Tosoh Bioscience, and Trinity Biotech are observed as key market participants in the global glycated hemoglobin testing market. Their presence in the expansion of the global market for glycated hemoglobin testing during the forecast period is expected to be active and aggressive. Obtain the Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35429 About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ ^pop (Added: Sat Mar 16 2019 Hits: 125 Rating: 0.00 Votes: 0) Rate It

Pulse Lavage Systems Market Opportunities in Key Application Sectors by 2026 - Pulsed lavage is a type of mechanical hydrotherapy that uses an irrigating solution under pressure produced by an electrically powered device. This pressurized pulsed solution irrigates and debrides wounds of necrotic tissue. Irrigation under pressure may be delivered concurrently with suction to remove both irrigation solution and wound debris, which helps to improve granulation tissue growth without damaging the underlying normal tissues. Additionally, negative pressure created by the suction stimulates granulation and helps in speedy recovery of the wound. Pulsed lavage is used in wound cleansing to remove debris and infectious agents from a wound’s surface. This type of wound cleansing is also known as pulsatile lavage, mechanical lavage, high-pressure irrigation, lavage, jet lavage, or mechanical irrigation. This high-pressure wound irrigation system is commonly used in operating rooms and wound care facilities. Report Overview: https://www.transparencymarketresearch.com/pulse-lavage-systems-market.html The global pulse lavage systems market is projected to grow at a rapid pace in the next few years due to rise in the number of surgical procedures, technological advancements in development of surgical tools, surge in number of orthopedic procedures, increase in geriatric population, and rise in sports and road accident injuries. Growing medical tourism and opportunities in developing economies also contribute to the growth of the global pulse lavage systems market. However, delay in wound healing due to high pressure irrigation acts as restraint of the market. The global pulse lavage systems market can be segmented based on product type, usability, application, power source, and end-user. In terms of product type, the market can be bifurcated into pulse lavage devices & components and accessories. Based on usability, the global pulse lavage systems market can be categorized into disposable pulse lavage systems, semi-disposable pulse lavage systems, and reusable pulse lavage systems. The disposable lavage systems segment accounted for the largest market share in 2017, as these systems do not need maintenance and have low chances of cross-contamination. In terms of application, the market can be classified into orthopedics, wound care, and trauma. The orthopedics segment accounted for the largest market share and is expected to grow at a faster CAGR during the forecast period due to rise in prevalence of bone disorders such as osteoarthritis because of increase in geriatric population and obesity rates. Based on power source, the global pulse lavage systems market can be divided into battery-powered, gas-powered, and AC-powered. The battery-powered segment accounted for the largest market share in 2017 and is estimated to expand at a faster CAGR due to high demand for battery powered devices among end-users owing to high energy storage capabilities and low maintenance cost. In terms of end-user, the market can be categorized into hospitals & clinics and long-term care facilities. The hospitals & clinics segment dominated the global pulse lavage systems market in 2017 due to increase in admissions in hospitals for surgical procedures and wound care. Obtain the Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=59748 In terms of region, the global pulse lavage systems market can be segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. North America accounted for the largest share of the global market in 2017 due to increase in the geriatric population, rise in prevalence of bone disorders, surge in orthopedic procedures, and relatively greater access to health care. Asia Pacific is projected to be the fastest growing market due to high government focus on health care sector, increase in the geriatric population, rise in prevalence of chronic diseases, and economic growth in several countries. Key players operating in the global pulse lavage systems market include Smith & Nephew plc, Stryker Corporation, MicroAire Surgical Instruments, LLC, Zimmer Biomet, Mölnlycke Health Care, Corin Orthopaedics Holding Ltd., Heraeus Holding GmbH, C. R. Bard, Inc., Judd Medical Ltd., and Atlantic Surgical Ltd. Request for Discount on the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=59748 About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ ^pop (Added: Sat Mar 16 2019 Hits: 116 Rating: 0.00 Votes: 0) Rate It

Leadless Pacemaker Market to Deliver Positive Growth Results until 2026 - Pacemakers were developed in the 1950s and were mainly aimed at treating life-threatening heart blockages that occur after cardiac surgery. Though these devices were able to increase the life span, they were plagued by many disadvantages, including short life span of the battery, lead failure, and infections caused due to surgery. Many of these same issues are present today with most left ventricular assisted pacemaker devices. With advancements in technology, the size of pacemakers has reduced significantly, which allowed for the first pacemaker to be implanted in Sweden in 1958. Trans-venous lead was developed and first used in pacemaker devices by Parsonnet etal. These early pacemakers had limited functionality and could only perform asynchronous pacing. Rapid advances have been made with pacemaker technology, including rate and output, to allow noninvasive communication with devices and improved battery technology in order to extend the life span of the pulse generator by one year. Report Overview: https://www.transparencymarketresearch.com/leadless-pacemaker-market.html Trans-venous cardiac pacemakers have improved life and reduced mortality for patients. However, these pacemakers are still associated with many potential device-related complications. It is estimated that around 10% of patients experience complications related to trans-venous implantation of pacemakers. Conventional pacemakers are reliable, but they still face many limitations that arise from the subcutaneous pocket where pacemakers are placed. These may give rise to skin erosion. The use of trans-venous lead can lead to pneumothorax or deep vein thrombosis. Leadless pacemakers are of two types: single chambered and double chambered. Until now around five million conventional pacemakers have been implanted worldwide, and out of these, nearly 20% cases have failed annually because of lead wiring. In order to eradicate the difficulty arising due to lead wiring, researchers have developed leadless pacemakers. Leadless pacemakers are designed to achieve the same pacing result as conventional pacemakers. Leadless pacemakers are self-contained devices that can be easily implanted within the right ventricle of the heart without surgery through the use of a catheter induced via the veins in the leg, thus leaving no scar marks. The major drivers of the global leadless pacemaker market are an increase in the geriatric population, rise in the incidence of cardiovascular disorders, technological advancements, increase in health care expenditure, and rise in in favorable government reforms for promoting health care facilities. Moreover, other factors such as avoiding the use of harmful lead, no infections and scar marks, MRI compatibility, and no postoperative mobility restriction are anticipated to boost the global leadless pacemaker market. However, factors such as lack of adequate personnel to perform procedures, reimbursement issues, and high cost of implantation are expected to drive the global leadless pacemaker market. The cost of leadless pacemakers is approximately four times that of conventional pacemakers. Obtain the Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=59745 The global leadless pacemaker market can be segmented based on technology, end-user, and geography. In terms of technology, the global leadless pacemaker market can be divided into single chambered, double chambered, subcutaneous ICD leadless pacing, and other. Based on end-user, the leadless pacemaker market can be classified into hospitals, ambulatory surgical centers, academic & research institutes, and others. Based on geography, the global leadless pacemaker market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to lead the global leadless pacemaker market, due to high prevalence of cardiac-related diseases and presence of major players in the global leadless pacemaker market. The market in North America was closely followed by that in the European region. The leadless pacemaker market in Asia Pacific is anticipated to provide a lucrative market opportunity during the forecast period, owing to increasing patient population, technological advancements, and rising demand for efficient pacing systems. The market in Latin America and Middle East & Africa is expected to expand due to an increase in focus of manufacturers in the region for business expansion. Major players operating in global leadless pacemaker market are Abbott, Medtronic’s, Boston Scientific Corporation, Biotronik, and others. Increase in product approvals and technological advancement is expected to drive the market during the forecast period. For instance, Micra Trans-catheter Pacing System (TPS) pacemaker by Medtronic’s received the U.S. FDA approval in April 2016. Request for Discount on the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=59745 About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Sat Mar 16 2019 Hits: 25 Rating: 0.00 Votes: 0) Rate It

Global Tissue Engineering Regeneration Market to Witness Significant Revenue Growth Through 2020 - Tissue Engineering is a process involving in-vitro development of tissues or organs. It is done to replace or support the function of defective or injured body part. Tissue engineering involves the application of biology and engineering for innovation of tissue substitutes that can maintain, restore and improve the function of ruptured human tissue. Products developed by this procedure are efficient and durable. Tissue engineering is gaining its popularity in various areas such as burn treatment or wound care, neurology products, orthopedics, urological products and others. On the basis of type of material used, tissue engineering and regeneration market can be segmented into synthetic, genetically modified and biological materials. In terms of technology, tissue engineering and regeneration market can be segmented into immunoisolation technology, cell culture technology and stem cell technology. On the basis of its applications, orthopedic and dermal sections have the largest market in tissue engineering and regeneration market. North America dominates the global market for tissue engineering and regeneration due to large number of aging people and increasing desire for such surgeries in the region. Europe is expected to experience less growth rate as compared to Asia. This is due to more stringent laws and regulations present in the region. Asia is expected to experience high growth rate in global tissue engineering and regeneration market. Some of the key driving forces for growth of tissue engineering and regeneration market in emerging countries are increasing pool of patients and increasing awareness in these regions. Request For Report Sample@ https://www.persistencemarketresearch.com/samples/2989 Rising cost of organ transplantation and increasing medical applications of 3D printing in tissue and organ regeneration are driving the global tissue engineering and regeneration market. In addition, this technology is gaining popularity due to its efficient products and reduced rejection rates. Varied applications of this technology, for instance, its woundcare followed by orthopedics applications has been driving this market at a high growth rate. Dental and neurologic applications are also expected to drive tissue engineering and regeneration market in near future. Globally, number of regeneration surgeries performed is increasing every year. According to Clearpoint Medical, which is involved in designing, manufacturing and distribution of compression wear, in 2013, in the U.S., number of reconstruction procedures performed increased by 2% from that in year 2012 and reached a number of about 5.6 million. However, due to slow development, high costs involved in procedure and increasing biological complexity of tissue engineering and regeneration procedures, the global tissue engineering and regeneration market is expected to impede. Request For Report Table of Content (TOC): https://www.persistencemarketresearch.com/toc/2989 Recent developments in the field of regeneration surgeries, particularly stem cell research, is expected to offer new opportunities for global tissue engineering and regeneration market. Big companies dealing in the market have been involved in partnerships, mergers and acquisitions with smaller companies. This is one the major trends observed in the global tissue engineering and regeneration market. In addition, companies are focussing on approval and patents for their products. Some of the major companies dealing in Tissue engineering and regeneration market are Advanced Cell Technology, Integra LifeSciences, CryoLife, BioMimetic Therapeutics, Sanofi, StemCellsInc, Cook Biotech, LifeCell Kinetic Concepts, Arteriocyte and BioTissue Technologies. ^pop (Added: Fri Mar 15 2019 Hits: 121 Rating: 0.00 Votes: 0) Rate It

Unintentional Injuries Patient recently moved by Vedanta Air Ambulance from Mumbai - March 15, 2019- A top-ranking air ambulance service provider company in India which is none other than Vedanta Air Ambulance recently moved one Marburg virus suffering patient from Mumbai to Chennai. What is the meaning of this Injuries? Unintentional Injuries Accidents cause 4.6% of deaths crossways the nation. India is rated as the number 1 country when it comes to deaths in road accidents! Main Causes 1. Negligence 2. Road conditions 3. Weather conditions Prevention Methods Drive carefully Follow rules Carry a first aid kit Vedanta Air Ambulance is really providing all types of emergency services to evacuate the serious patients from this city to another city by private charted aircraft or commercial airlines medical facility under the highly experienced, well-trained medic team including MD doctors and paramedical technicians as well as all species of emergency equipment. It is based on the whole time casual service providing assistance which has great channels of ICU specialist MD doctors’ panels and long time experienced and working for paramedical technicians’ ; those all are ready with all the emergency equipment in which hi-tech and portable ventilator, cardiac monitor, suction machine, infusion pump, nebulizer machine, oxygen cylinders, pacemakers, defibrillator, and all the basic and advance facility to shift the critical patients from one bed to another bed. Hire Air Ambulance from Mumbai offers always lower rate and after the updating lowest cost to the needy and it is possible only by Cost of Vedanta Air Ambulance Vellore which always believes in quality, safety, experience, transparency and economic cost in connection with the serious ones anytime, anywhere, and anyhow only after call confirmation. Avail Air Ambulance from Chennai which is one of the most time saving, intense assistance and quick service providers by private charter aircraft, commercial airlines evacuation system, medical transfer facility and much more transfer service available. Web@ https://www.vedantaairambulance.com/air-ambulance-in-mumbai/ More@ https://www.vedantaairambulance.com/air-ambulance-in-chennai/ (Added: Fri Mar 15 2019 Hits: 13 Rating: 0.00 Votes: 0) Rate It

Sales Forecasts of Medical Practice Management Software Reveal Positive Outlook Through 2020 - Medical practice management software (PMS) is extensive healthcare software which is used in day to day operations of medical practices. Medical practice management software capture, stores, manages and transmits information related to the health of individuals or the activities of organizations that work within the healthcare sector. Medical practice management software helps in integration of electronic health records (EHR) to provide interoperability solutions and assist in the overall practice management process. In addition, the medical practice management software helps in real time verification of the patients, schedule appointments, patient’s registration. Medical practice management software also helps in various other processes such as medical billing, storing demographics data, maintaining list of insurance payers, claim management, billing tasks and others. North America has the largest market for medical practice management software due to rising government initiatives in these regions. Europe followed by the Asia is expected to experience high growth rate in the global medical practice management software market. This is due to increasing awareness and increasing technological advancement in the region. Some of the key driving forces for medical practice management software market in emerging countries are large pool of patients and rising government funding in these regions. Request For Report Sample@https://www.persistencemarketresearch.com/samples/2981 Increasing demand for better healthcare facilities, need of high return on investment, rising government initiatives, increasing need for integrated healthcare systems and raising investments from healthcare IT players are some of the key factors driving the growth for global medical practice management software market. In addition, increasing healthcare awareness is also driving the global medical practice management software market. However, lack of experienced professionals, interoperability issues, huge time consumptions for integration and high maintenance and service expenses are some of the major factors restraining the growth for global medical practice management software market. Request For Report Table of Content (TOC): https://www.persistencemarketresearch.com/toc/2981 IT-enabled healthcare solutions for physicians and emerging markets are expected to offer opportunities to medical practice management software market. However, lack of data confidentiality and shortage of on-site IT support services are some of the challenges that have been observed for the global medical practice management software market. Wireless and cloud technology are getting popular. In addition, companies are focussing on development of products with patient centric approach. These are some major trends which have been observed in the medical practice management software market. Some of the major companies operating in the global medical practice management software market are Allscripts, GE Healthcare, athenahealth, Inc., MediTouch, CERNER CORPORATION, McKesson Corporation, Epic Systems Corporation, NextGen Healthcare Information System LLC, MEDITECH, eClinicalWorks and Greenway Health, LLC. ^pop (Added: Fri Mar 15 2019 Hits: 94 Rating: 0.00 Votes: 0) Rate It

Demand for Intravenous Immunoglobulin to Witness Rapid Surge During the Period 2014 to 2020 - The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors. Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia, get benefit from IVIg to maintain the appropriate level of antibodies in the body. The global market of IVIg is categorized based on plasma protein and by therapeutic area. The plasma protein segment is further sub-segmented in polyvalent IVIg, albumin, Factor VIII, hyperimmunes (IM&IV) and Factor IX. Polyvalent IVIg sub-segment holds the largest market share in global IVIg market. Moreover, the therapeutic area segment includes immune deficiencies, autoimmune diseases and acute infections. The immune deficiency sub-segment comprises major diseases, such as, hypogammaglobulinemia (primary immune deficiencies), X-linked agammaglobulinemia and acquired compromised immunity conditions (secondary immune deficiencies), featuring low antibody levels. The autoimmune disease sub-segment includes immune thrombocytopenia (ITP) and Inflammatory diseases. Request For Report Sample@ https://www.persistencemarketresearch.com/samples/2830 In terms of geography, North America is the largest market for IVIg followed by Europe and Asia. In North America, the U.S. represents the largest market for IVIg. In Europe, Germany, France and the U.K. covers the major share of IVIg market. Asia represents the fastest growing market for IVIg, due to increasing aging population. Elderly people are more susceptible to antibody deficiency diseases. Globally, IVIG market is witnessing a strong growth due to increasing number of patients with bleeding disorders, rising geriatric population and increasing number of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) patients. Moreover, increasing investment in healthcare sector is also supporting in growth of IVIg market. In addition, increasing number of patients suffering with autoimmune diseases and other pathological conditions are also supporting growth of IVIg products in the market. However, stringent regulations hamper the growth of the IVIg market. Several government associations have imposed strict guidelines for appropriate usage of IVIg products. For instance, Canadian Blood Services and National Advisory Committee on Blood and Blood Products of Canada provide practice guidelines on the usage of IVIg products in hematological diseases. Request For Report Table of Content (TOC): https://www.persistencemarketresearch.com/toc/2830 In addition, high treatment cost also impedes growth of IVIg market. Some patients cannot afford IVIg products, due to high cost of their treatment. IVIg products are very expensive as the materials required to produce them cost more and the manufacturing process requires a significant amount of blood samples from donors. The collection of large amount of blood samples is a very complex and tedious process. Furthermore, high risks of side-effects associated with IVIg treatment also restrain growth of the IVIg market. Some of the major side-effects of IVIg treatment are headache, migraine, dizziness, fever, nausea, vomiting, fast heart rate, itching, high blood pressure, cough and abdominal pains. These side-effects inhibit the acceptance of IVIg products by many patients. Some of the key players operating in IVIg market are Baxter International Inc., Beijing Tiantan Biological Products Co., Ltd., Biotest AG, China Biologic Products, Inc., CSL Limited, Guizhou Taibang Biological Products Co., Ltd., Shanghai RAAS Blood Products Co., Ltd., Octapharma AG, Grifols, S.A, Hualan Biological Engineering Inc., OMRIX Biopharmaceuticals Ltd. and Kedrion S.p.A. (Added: Fri Mar 15 2019 Hits: 54 Rating: 0.00 Votes: 0) Rate It

Electrosurgery Accessories Market Growth Analysis, Competitor Landscape, Opportunity - Electrosurgery accessories are the additional products used in electrosurgical procedures. Electrosurgery is the application of a high-frequency alternating polarity radio wave, this high-frequency waves are used to cut, coagulate, desiccate, or fulgurate biological tissues. The electrosurgery accessories are used in different types of procedures such as gynecological, urological, neurological, and cosmetic surgeries. Pencils, specialty electrodes, return electrodes, suction coagulators, forceps, cords, and adapters are the most commonly used electrosurgery accessories. The accessories and technologies used in electrosurgeries are minimally invasive with less pain, less blood loss, minimum scarring, and reduced hospital stay. This has resulted in increasing demand for electrosurgical procedures by large patient population. New technological advancements, sophisticated products, and research studies in electrosurgery are highly contributing to the electrosurgery accessories market growth. Global Electrosurgery Accessories Market: Drivers The electrosurgery accessories market revenue is expected to rise, owing to increasing number of new product launches with latest technology. For instance, in 2018, Olympus Corporation launched dualknife J endoscopic submucosal dissection (ESD), an electrosurgical knife, which integrates submucosal injection to support efficient, safe, and more reliable ESD performance in short procedure time. Furthermore, the electrosurgery accessories market size is also increasing due to rising demand for ambulatory surgeries by patients, as ambulatory surgeries involve electrosurgery associated with less pain, less blood loss, minimum scarring, and reduced hospital stay. According to Healthcare Cost and Utilization Project (HCUP) 2014 report, around 11.4 million outpatient surgeries were performed in the U.S. in 2014. Get HOLISTIC Request Sample Copy Of This Business Report: https://www.coherentmarketinsights.com/insight/request-sample/2540 Global Electrosurgery Accessories Market: Restraints The major restraining factor for electrosurgery accessories market growth is risk of accidents and fire cases due to inadequate knowledge about handling electrosurgery accessories such as specialty electrodes, return electrodes, and suction coagulators. According to the National Center for Biotechnology Information (NCBI) 2016 report, around 57% of surgeons lack adequate knowledge and awareness in managing the equipment in Ireland. Product recalls due to technical faults is another factor hampering the electrosurgery accessories market size. For instance, in 2018, the U.S. Food and Drug Administration recalled the product bipolar cord from Olsen Medical Group under Class 2 Device Recall, as the product was intruding into the sterile pouch seal during the surgical procedures, thereby increasing the risk of the seal being compromised. Global Electrosurgery Accessories Market: Regional Analysis Europe is expected to hold dominant position in the electrosurgery accessories market over the forecast period, owing to the presence of major competitors with new innovative products such as Medtronic PLC, B. Braun Melsungen AG, KLS Martin GmbH & Co. Kg, and Bowa-Electronic GmbH & Co. Kg. Asia Pacific electrosurgery accessories market size is expected to witness significant growth in future, owing to new product launches in the region for ease of electrosurgical procedures. For instance, in 2018, Integra Lifesciences Holdings Corporation announced the launch of its new CUSA clarity ultrasonic tissue ablation platform in Japan. It is made in combination with ISOCOOL Bipolar Forceps, which as integral part of the product. Global Electrosurgery Accessories Market: Competitive Landscape Key players operating in the global electrosurgery accessories market include Medtronic PLC, Olympus Corporation, Conmed Corporation, B. Braun Melsungen AG, Bovie Medical Corporation, Ethicon, Inc. (subsidiary of Johnson & Johnson), Erbe Elektromedizin GmbH, Applied Medical Resources Corporation, Integra Lifesciences Holdings Corporation, KLS Martin Group, Megadyne Medical Products, Inc., and Bowa-Electronic GmbH & Co. Kg. Click To Reading More On Electrosurgery Accessories Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:sales@coherentmarketinsights.com (Added: Fri Mar 15 2019 Hits: 27 Rating: 0.00 Votes: 0) Rate It

World Heart Congress 2019, the world’s leading Conference for Cardiology and Cardiac treatment - The Cardiology Conferences is proud to announce that its annual congress will be held in Vienna, Austria during August 19-20, 2019. As the world’s premier cardiology conference 7th World Heart Congress (World Heart Congress 2019) is a rich mix of Interactive Sessions & Sub-sessions, keynote lectures from industry experts, panel discussions, poster competitions and Young Researcher Forums. The global cardiology market constitutes cardiac biomarkers, interventional cardiology and cardiovascular devices. It found that the global market for in vitro diagnostic tests for cardiac biomarkers was estimated at $3.1 billion in 2012 and nearly $4 billion in 2013. This market is predicted to reach $7.2 billion by 2019, at a compound annual growth rate (CAGR) of 12.8% over the five-year period from 2013 to 2018. And the global market for emerging medical device technologies should reach $90.8 billion by 2021 from $55.9 billion in 2016 at a compound annual growth rate (CAGR) of 10.2%, from 2016 to 2021. Cardiology Conferences look forward to even greater success in this coming year’s conference 7th World Heart Congress which is scheduled in the City of Music and City of Dreams, Vienna during August 19-20, 2019 Vienna the city of Music and city of dreams there are different things to see, places to go and stuff to do. Vienna is cited as one of the most beautiful city in Europe. It was always an amazing idea to have a trip to Vienna! Vienna Waits For You! It is a wondrous city for adults and kids alike. Its beauty is etched in its pores and is lit up from within its core– from its culture and architecture to its history and food. Baroque streetscapes and imperial palaces set the stage for Vienna's artistic and musical masterpieces alongside its coffee-house culture and vibrant epicurean and design scenes makes you to fall in love with the city. Therefore this meeting will also provide an opportunity to the attendees for exploring the exciting tourist attractions along with their attendance at the conference. It is an Alpha- global city with strengths in the healthcare, research, education, media, commerce, design, and tourism. This meeting will be fulfilled by the participation of eminent cardiologists, cardiac surgeons, cardio-thoracic surgeons, cardiac nurses, scientists, professors, medical students and business professionals from pharmaceutical companies from every corner of the world so that they can discuss their ideas and views on their respective research works amongst others. The main topics of the event are- Heart Diseases, Heart Failure Hypertension, Electrocardiography, Pediatric & Geriatric Cardiology, Interventional Cardiology, Cardio-oncology, Diabetes & Heart, Cardio-thoracic Surgery, and Cardiac Nursing and so on. Web source: https://heart.insightconferences.com/ Contact: Andrea Jones Program Director World Heart Congress 2019 Email: heart_congress2019@rediffmail.com ^pop (Added: Fri Mar 15 2019 Hits: 152 Rating: 0.00 Votes: 0) Rate It

PHARMA MEET 2019 - Gavin Conferences cordially invites each and every interested and enthusiastic participant from all over the world to take part in the International Conference on Pharmaceutical Sciences and Drug delivery, at Milan, Italy during 18-19 of November 2019. Pharma Meet 2019 is the most suitable platform to explore ones’ scientific knowledge by sharing through their presentations and to build a robust network with the eminent people, key decision makers from established universities, Healthcare Institutes, Pharmaceutical, Biotech organizations of the world. The conference aims to make a powerful belief that health and medical sciences will surely create a healthy circumstances by the inter-bonding with the Pharmaceutical studies and sciences and therefore the theme “Optimizing Research reforms of the Pharmaceutical Industry” Website: https://pharma-drugdesigning.gavinconferences.com/ Email: pharmameet2019@gmail.com Conference Highlights: 1.Pharmacological studies 2.Pharmacy and Pharmaceutical sciences 3.Pharmaceutical Biotechnology and Microbiology 4.Clinical Trials and Clinical Research 5.Pharmaceutical Nanotechnology 6.Drug Theraphy of Neurodegenarative disorders 7.Biopharmaceutics 8.Pharmacology and Toxicology 9.Medicinal Chemistry and Drug discovery 10.Advanced Nanomedicine 11.Pharmacokinetics and Pharmacodynamics 12.Bioavailability and Bioequivalence 13.Cancer Pharmacology 14.Immunotherapy and Vaccines in Drug delivery 15.Public health 16.Industrial Pharmacy and Pharmacognosy 17.Contract Research Organizations / Interprenuer Investment 18.Future of Pharma R&D 19.Pharmaceutical Business management 20.Regulatory Affairs and Intellectual Property Rights (Added: Fri Mar 15 2019 Hits: 34 Rating: 0.00 Votes: 0) Rate It

Benign Prostatic Hyperplasia (BPH) Prostate Treatment Industry -

The approximately US$ 25 Bn market for benign prostatic hyperplasia prostate treatment is likely to expand at 4.6% CAGR during 2018-2028, according to a recent research report of Future Market Insights (FMI). The report has envisaged steady growth prospects for the revenue of global benign prostatic hyperplasia prostate treatment market through 2028.

The World Population Prospects’ data (2017) projected that the number of individuals aged 60 years and above will double by 2050, and triple by 2100. With such a high pace estimated for the growth of population aged 60 years and above, it is more likely that the prevalence of aging related health conditions will also increase at a considerable pace in the years to come. A high prevalence rate of benign prostatic hyperplasia (BPH) in men, the demand for improved and more effective treatment options continues to increase at a high rate.

Alpha-blockers & Drugs for Lower UTIs Remain Pivotal in Benign Prostatic Hyperplasia Prostate Treatment

The drug treatment has been vital in treating benign prostatic hyperplasia conditions and lower UTIs, which has been attributed to widespread availability of drug-based benign prostatic hyperplasia prostate treatment. This factor, in particular, will play an instrumental role in driving the growth of the benign prostatic hyperplasia prostate treatment market during the forecast period. Drugs will remain the first choice of treatment for benign prostatic hyperplasia.

Benign prostatic hyperplasia increases the risk of other disorders as well. The most common disorder caused due to benign prostatic hyperplasia is lower UTI (urinary tract infection) for which, Alpha-blockers constitute the first line of treatment. However, other drugs are also available in the market, which offer relief from the benign prostatic hyperplasia symptoms. Other drugs include alpha reductase inhibitors, phosphodiesterase-5 (PDE-5) inhibitors, muscarinic receptor antagonists, and combination drugs.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1664

Demand for Benign Prostatic Hyperplasia Prostate Treatment Higher in Developed Regions, Patient Pool Expanding Steadily in Developing Markets

Owing to significantly growing prevalence of benign prostatic hyperplasia in North American men, benign prostatic hyperplasia prostate treatment market is expected to witness strong growth within the region, followed by Europe.

Extensive availability of benign prostatic hyperplasia prostate treatments, increasing clinical trials, improving R&D scenario, higher healthcare spending, and favorable government initiatives will continue to assist the growth of the benign prostatic hyperplasia prostate treatment market in developed regions.

On the other side, Asia Pacific’s benign prostatic hyperplasia prostate treatment market is foreseen to witness significant growth, owing to steadily expanding patient pool due in the region.

UroLift System to Revolutionize the Competitive Landscape of Benign Prostatic Hyperplasia Prostate Treatment Market

Teleflex Incorporated’s NeoTract recently launched UroLift® System as a highly effective, least invasive option for benign prostatic hyperplasia prostate treatment. The UroLift® System is permanently implanted via a transurethral outpatient procedure and predominantly relieves prostate obstruction, which is one of the primary symptoms of benign prostatic hyperplasia. The company has also declared insurance coverage for UroLift® System. While the coverage is being provided by Humana, it is most likely to improve awareness about increasing availability and broadening access of minimally invasive treatment methods in urological conditions such as benign prostatic hyperplasia. This in turn will encourage adoption of UroLift® System among patients seeking effective benign prostatic hyperplasia prostate treatment.

Request to View Methodology @ https://www.futuremarketinsights.com/askus/rep-gb-1664

A majority of patients with enlarged prostate continue to perceive medication and surgery as the only available treatment alternatives. However, an increasing number of physician recommendations is advocating the use of The UroLift® System as it eliminates side effects associated with other conventional options of benign prostatic hyperplasia prostate treatment.
^pop (Added: Fri Mar 15 2019 Hits: 107 Rating: 0.00 Votes: 0) Rate It

Pages: [<<] ... 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 ... [>>]

Links SQL By: Gossamer Threads Inc.

Alpha-blockers & Drugs for Lower UTIs Remain Pivotal in Benign Prostatic Hyperplasia Prostate Treatment

Demand for Benign Prostatic Hyperplasia Prostate Treatment Higher in Developed Regions, Patient Pool Expanding Steadily in Developing Markets

UroLift System to Revolutionize the Competitive Landscape of Benign Prostatic Hyperplasia Prostate Treatment Market